Specialist Chapter: Trends and Strategies in Global Pharma and Biotech Patent Litigation

International patent protection is now part-and-parcel for any significant drug or therapeutic, and, as a result, disputes over patent ownership and infringement now regularly implicate a myriad of related laws across international venues. In this article, the authors analyze a handful of recent global patent disputes in pharma and discuss how differing local laws can affect litigants and substantive outcomes, and how parties can leverage international patent disputes. This article was first published by IAM in January 2024. For further in-depth analysis, please visit IAM The Patent Litigation Review 2024.